Tag Archives: Science Translational Medicine
A Weekly Advocacy Message from Mary Woolley: Does Congress care if Nobel laureates of the future are put at risk?
Dear Research Advocate:
Like most Americans, we are alarmed by the ongoing government shutdown. Since the shutdown began, I have been in Georgia, Massachusetts and Ohio, speaking to business and academic leaders, state and local elected officials, philanthropic leaders, and working scientists. Everyone is outraged! Clearly, biomedical and health research — already compromised via sequestration — is not the only priority placed at risk by the impasse, but it is a critical one. From limiting access to clinical trials to undermining the ability to protect our food supply or investigate disease outbreaks, Americans are put at unnecessary risk when government employees are furloughed. We sent letters at the end of last week to Members of Congress and the president, urging action. We received responses from offices on both sides of the aisle: Many spoke passionately of their support for medical research; some hewed the party line; others lamented the budget impasse.
We are doing everything we can to keep the spotlight on the damage done to medical and health research when the government is shut down. When the public and its policy makers look back on the 2013 shutdown, we want them to remember which government functions most tellingly exemplified the cost — fiscal and societal — our nation incurs when the ability to function is derailed. Continue reading →